Support for a TAVR-first approach in patients with concurrent valve and coronary disease
While procedural success rates lag overall, they shine for retrograde crossing
Randomized WATCH-TAVR trial confirms safety of the combined procedures
Lower success rates, more hospital MACE seen with poor-quality distal targets
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Number of stent layers correlates with worse outcomes
Black and white patients realize similar gains following adoption of new protocol
Cleveland Clinic experience is applicable to other laboratories
Results from largest randomized trial of the technology to date
Pivotal COSIRA-II multicenter U.S. clinical trial is underway
Protocol promises to shape patient satisfaction, hospital resource utilization